These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36495042)
1. Increased recombinant adeno-associated virus production by HEK293 cells using small molecule chemical additives. Scarrott JM; Johari YB; Pohle TH; Liu P; Mayer A; James DC Biotechnol J; 2023 Mar; 18(3):e2200450. PubMed ID: 36495042 [TBL] [Abstract][Full Text] [Related]
3. Enhanced ER protein processing gene expression increases rAAV yield and full capsid ratio in HEK293 cells. Fu Q; Wang Y; Qin J; Xie D; McNally D; Yoon S Appl Microbiol Biotechnol; 2024 Sep; 108(1):459. PubMed ID: 39230729 [TBL] [Abstract][Full Text] [Related]
4. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector. Grieger JC; Soltys SM; Samulski RJ Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810 [TBL] [Abstract][Full Text] [Related]
5. Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells. Liu S; Li J; Peraramelli S; Luo N; Chen A; Dai M; Liu F; Yu Y; Leib RD; Li Y; Lin K; Huynh D; Li S; Ou L Mol Ther; 2024 Jan; 32(1):74-83. PubMed ID: 37990495 [TBL] [Abstract][Full Text] [Related]
6. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Ran G; Feng XL; Xie YL; Zheng QY; Guo PP; Yang M; Feng YL; Ling C; Zhu LQ; Zhong C J Integr Med; 2021 Nov; 19(6):515-525. PubMed ID: 34538767 [TBL] [Abstract][Full Text] [Related]
7. Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production. Wu Y; Mei T; Jiang L; Han Z; Dong R; Yang T; Xu F Hum Gene Ther Methods; 2019 Oct; 30(5):172-183. PubMed ID: 31566024 [TBL] [Abstract][Full Text] [Related]
8. Infectivity Assessment of Recombinant Adeno-Associated Virus and Wild-Type Adeno-Associated Virus Exposed to Various Diluents and Environmental Conditions. Tomono T; Hirai Y; Chono H; Mineno J; Ishii A; Onodera M; Tamaoka A; Okada T Hum Gene Ther Methods; 2019 Aug; 30(4):137-143. PubMed ID: 31317781 [TBL] [Abstract][Full Text] [Related]
9. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400 [TBL] [Abstract][Full Text] [Related]
10. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy. Mietzsch M; Grasse S; Zurawski C; Weger S; Bennett A; Agbandje-McKenna M; Muzyczka N; Zolotukhin S; Heilbronn R Hum Gene Ther; 2014 Mar; 25(3):212-22. PubMed ID: 24299301 [TBL] [Abstract][Full Text] [Related]
11. Popularizing Recombinant Baculovirus-derived OneBac System for Laboratory Production of all Recombinant Adeno-associated Virus Vector Serotypes. Wu Y; Han Z; Duan M; Jiang L; Tian T; Jin D; Wang Q; Xu F Curr Gene Ther; 2021; 21(2):167-176. PubMed ID: 33461466 [TBL] [Abstract][Full Text] [Related]
13. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery. Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498 [TBL] [Abstract][Full Text] [Related]
14. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells. Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815 [TBL] [Abstract][Full Text] [Related]
15. A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy. Dong B; Moore AR; Dai J; Roberts S; Chu K; Kapranov P; Moss B; Xiao W Nucleic Acids Res; 2013 Jul; 41(13):6609-17. PubMed ID: 23677609 [TBL] [Abstract][Full Text] [Related]
16. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors. Hirsch ML; Wolf SJ; Samulski RJ Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576 [TBL] [Abstract][Full Text] [Related]
17. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Urabe M; Ding C; Kotin RM Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305 [TBL] [Abstract][Full Text] [Related]
18. Direct Head-to-Head Evaluation of Recombinant Adeno-associated Viral Vectors Manufactured in Human versus Insect Cells. Kondratov O; Marsic D; Crosson SM; Mendez-Gomez HR; Moskalenko O; Mietzsch M; Heilbronn R; Allison JR; Green KB; Agbandje-McKenna M; Zolotukhin S Mol Ther; 2017 Dec; 25(12):2661-2675. PubMed ID: 28890324 [TBL] [Abstract][Full Text] [Related]
19. Production and purification of recombinant adeno-associated vectors. Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of rAAV titers via inhibition of the interferon signaling cascade in transfected HEK293 suspension cultures. Kahlig CI; Moser S; Micutkova L; Grillari J; Kraus B; Hernandez Bort JA Biotechnol J; 2024 May; 19(5):e2300672. PubMed ID: 38719621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]